The U.S. president's social media post put pressure on drug-related stocks on worries their profits will take a hit if they ...

Shares of Asian pharmaceutical companies fell after US President Donald Trump said he planned to order a cut in US ...

President Donald Trump said he plans to order a cut in US prescription drug costs by mandating that Americans pay no more ...

His announcement is pressuring pharma stocks on worries their profits will take a hit if they have to cut prices in the US.

He plans to sign an executive order to cut prescription drug prices. Read more at straitstimes.com. Read more at straitstimes ...

Shares of Asian drugmakers are falling after President Trump said he would [sign an executive order]( ...

Shares of Asia drugmakers fell on Monday after President Trump said he would sign an executive order aimed at lowering the cost of prescription drugs.

Even as the markets gained substantially on expected lines in Monday's trade (May 12, 2025) after India-Pakistan agree ...

The trial’s primary endpoint is pCR, with secondary endpoints including event-free survival (EFS), overall survival, safety, ...

Less than three weeks after AstraZeneca and Daiichi Sankyo reported positive results for oncology powerhouse Enhertu in a ...

Daiichi Sankyo reaffirms US manufacturing expansion, including for Enhertu, will help with Trump's proposed tariffs. Ohio ...

AstraZeneca (AZ) and Daiichi Sankyo have shared positive results from a late-stage study of their HER2-directed antibody drug ...